Skip to main content

Table 2 Clinical and biochemical characteristics of PCOS-NAFLD patients and controls

From: Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS)

 

Non-PCOS (n = 12)

PCOS (n = 12)

p-value

Age, years

37.6 +/− 10.0

35.2 +/− 9.60

NS

Heights, cm

165.0 +/− 11.0

168.1 +/− 3.9

NS

Weight, kg

127.4 +/− 11.6

138.7 +/− 39.4

NS

BMI (kg/cm2)

44.1 +/− 3.9

45.0 +/− 3.6

NS

AST (U/L)

23.5 +/− 15.00

23.3 +/− 10.4

NS

ALT (U/L)

28.7 +/− 21.9

29.9 +/−15.3

NS

AST/ALT

0.96 +/− 0.35

0.85 +/− 0.24

NS

TCHOL (mg/dL)

187.3 +/− 31.2

178.5 +/− 34.9

NS

LDL (mg/dL)

101.4 +/− 27.5

108.1 +/−37.3

NS

HDL (mg/dL)

43.6 +/− 11.1

54.2 +/−14.6

NS

TRIG (mg/dL)

177.1 +/−110.52

133.7 +/−34.8

NS